Christopher Gibson - Mar 13, 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Mar 13, 2023
Transactions value $
$0
Form type
4
Date filed
3/15/2023, 07:03 PM
Previous filing
Mar 10, 2023
Next filing
Apr 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +3K +0.32% $0.00 942K Mar 13, 2023 Direct F1, F2
transaction RXRX Class A Common Stock Gift $0 -3K -0.32% $0.00 939K Mar 13, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -3K -0.05% $0.00 6.62M Mar 13, 2023 Class A Common Stock 3K $0.00 Direct F1, F2, F6
holding RXRX Stock Option (Right to Buy) 814K Mar 13, 2023 Class A Common Stock 0 $8.55 Direct F3
holding RXRX Stock Option (Right to Buy) 5.44K Mar 13, 2023 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 416K Mar 13, 2023 Class A Common Stock 0 $11.40 Direct F4
holding RXRX Stock Option (Right to Buy) 688K Mar 13, 2023 Class A Common Stock 0 $2.48 Direct F5
holding RXRX Class B Common Stock 535K Mar 13, 2023 Class A Common Stock 0 $0.00 by LAHWRAN-3 LLC F6, F7
holding RXRX Class B Common Stock 508K Mar 13, 2023 Class A Common Stock 0 $0.00 by LAHWRAN-4 LLC F6, F8
holding RXRX Class B Common Stock 124K Mar 13, 2023 Class A Common Stock 0 $0.00 by Gibson Family Trust F6, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents the conversion of Class B Common Stock into Class A Common Stock.
F3 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F6 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F7 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F8 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F9 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.